In the world of diseases, psoriatic arthritis is a double-edged sword. On one end you have the inflammation, joint pain, stiffness, and swelling that comes courtesy of arthritis. On the other end are the hallmark red, itchy, scaly patches of skin that psoriasis brings (consider yourself doubly blessed). According to the National Psoriasis Foundation, psoriatic arthritis affects about one million people in the United States. Most people with the disease develop psoriasis first and arthritis later. And it doesn’t take much for one disease to turn into the other especially in the way of the psoriasis. “When I think someone has psoriatic arthritis, I ll go on a rash hunt, and a lot of times, the only thing I’ll find is a little patch of psoriasis behind the ears,” says Martin Bergman, M.D., chief of the division of rheumatology at Taylor Hospital in Ridley Park, PA and clinical professor of medicine at Drexel University College of Medicine.
Ankylosing Spondylitis. The disease you can’t pronounce and likely had never heard of until you or a loved one got diagnosed. It’s relatively rare, but for the 300,000 people in the U.S. (less than one percent of the adult population) who have it, it can be a real pain literally. The disease, which affects the joints primarily in the lower back, can cause pain, stiffness, and damage, and not because of wear and tear, but thanks to inflammation, says Martin Bergman, M.D., chief of the division of rheumatology at Taylor Hospital in Ridley Park, PA, and clinical professor of medicine at Drexel University College of Medicine. “One of the hallmark symptoms we look for is back pain that’s worse in the morning and gets better throughout the day; another is back pain that awakens you at night.”
Allegheny Health Network Appoints Bill Johnjulio, MD, Chief Population Health Officer prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
email article
Now that Johnson & Johnson has joined Pfizer and Moderna in having a COVID-19 vaccine authorized in the U.S., the question on many people s minds is: who gets which vaccine?
Much of the discussion has focused on the differing vaccine efficacy numbers for the three products: those given for the J&J vaccine are in the 70% range, versus more than 90% for Pfizer s and Moderna s.
But the Biden administration and independent public health specialists insist that those figures aren t strictly comparable and the public shouldn t pay much attention to them.
Johnson & Johnson s is not an inferior vaccine, and we should not talk about who shouldn t get it; we should talk about how we can immunize hard-to-get populations, said Sarah Long, MD, a pediatric diseases physician at Drexel University College of Medicine in Philadelphia and a member of the CDC s Advisory Committee on Immunization Practices (ACIP), during an emergency meeting of the committee Monday.
CDC Backs J&J COVID Vax Now Comes the Hard Part medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.